Marinomed Biotech AG

€4.00As of Sun 8 Nov 2026, 12:00 UTC
VIE:MARIHealthcare
Country Austria
PE (Fwd) •••
TSR 8Y CAGR (32.13%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.23)
PE TTM 0.408
TSR TTM (80.70%)
Mkt cap €7.996M
ROIC (147.00%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€4.96
23.93%
(75.26%)
Hold 7|1|7|11|4
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.04
0.04
0.05
0.05
21.19%
27.66%
39.64%
34.95%
Revenue€M
0.395
0.403
0.402
0.420
8.85%
10.51%
4.34%
10.27%
Peers (US$8.978M)
Cap (US$)
PE
8.946M
2.587x
8.881M
14.01x
Capital
TTM
5Y
10Y
Leveragex
0.762
0.206
0.192
EBIT/Intx
4.078
0.247
0.235
Own earn%
(0.12)
67.55
81.23
Sh yield%
32.63
8.40
10.29
Owners
Insiders/Inst%
3.61
32.71
Short interest%
0.79
SBC / revenue%
4.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
10–15
$1 testx
—
Incr. ROIC%
1